[HTML][HTML] Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced non-small-cell lung cancer: A meta-analysis from 24 …
JW Gao, P Zhan, XY Qiu, JJ Jin, TF Lv, Y Song - Oncotarget, 2017 - ncbi.nlm.nih.gov
Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced
non-small-cell lung cancer: a meta-analysis from 24 randomized controlled trials - PMC Back …
non-small-cell lung cancer: a meta-analysis from 24 randomized controlled trials - PMC Back …
[PDF][PDF] Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced non-small-cell lung cancer: a meta-analysis from 24 randomized …
JW Gao, P Zhan, XY Qiu, JJ Jin, TF Lv, Y Song - pdfs.semanticscholar.org
Background: To assess the efficacy profile of erlotinib-based doublet targeted therapy
compared with erlotinib monotherapy for previously treated patients with advanced NSCLC …
compared with erlotinib monotherapy for previously treated patients with advanced NSCLC …
Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced non-small-cell lung cancer: a meta-analysis from 24 randomized …
JW Gao, P Zhan, XY Qiu, JJ Jin, TF Lv… - Oncotarget, 2017 - pubmed.ncbi.nlm.nih.gov
Background To assess the efficacy profile of erlotinib-based doublet targeted therapy
compared with erlotinib monotherapy for previously treated patients with advanced NSCLC …
compared with erlotinib monotherapy for previously treated patients with advanced NSCLC …
[HTML][HTML] Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced non-small-cell lung cancer: a meta-analysis from 24 …
JW Gao, P Zhan, XY Qiu, JJ Jin, TF Lv, Y Song - Oncotarget, 2017 - oncotarget.com
Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced
non-small-cell lung cancer: a meta-analysis from 24 randomized... | Oncotarget Online ISSN …
non-small-cell lung cancer: a meta-analysis from 24 randomized... | Oncotarget Online ISSN …
Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced non-small-cell lung cancer: a meta-analysis from 24 randomized …
JW Gao, P Zhan, XY Qiu, JJ Jin, TF Lv, Y Song - Oncotarget, 2017 - europepmc.org
Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced
non-small-cell lung cancer: a meta-analysis from 24 randomized controlled trials. - Abstract …
non-small-cell lung cancer: a meta-analysis from 24 randomized controlled trials. - Abstract …
Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced non-small-cell lung cancer: a meta-analysis from 24 randomized …
JW Gao, P Zhan, XY Qiu, JJ Jin, TF Lv, Y Song - Oncotarget, 2017 - oncotarget.com
Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced
non-small-cell lung cancer: a meta-analysis from 24 randomized... | Oncotarget Online ISSN …
non-small-cell lung cancer: a meta-analysis from 24 randomized... | Oncotarget Online ISSN …
Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced non-small-cell lung cancer: a meta-analysis from 24 randomized …
JW Gao, P Zhan, XY Qiu, JJ Jin, TF Lv, Y Song - Oncotarget, 2017 - europepmc.org
Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced
non-small-cell lung cancer: a meta-analysis from 24 randomized controlled trials. - Abstract …
non-small-cell lung cancer: a meta-analysis from 24 randomized controlled trials. - Abstract …